Who owns ACRIVON THERAPEUTICS INC?
- Ticker: ACRV
- CUSIP Number: 004890109
Tip: Access positions for across all investors
Analyze quarterly positions in Acrivon Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acrivon Therapeutics stock
Who bought or sold ACRIVON THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 8.3M | $58M | 0% | Sep 2024 |
|
| Perceptive Advisors | 5.4M | $38M | 0% | Sep 2024 |
|
| Citadel Advisors | 2.1M | $15M | 1% | Sep 2024 |
|
| Sands Capital Ventures | 2.1M | $15M | 28% | Sep 2024 |
|
| Marshall Wace | 810k | $5.7M | -15% | Sep 2024 |
|
| BlackRock | 787k | $5.5M | 100% | Sep 2024 |
|
| BlackRock | 767k | $4.4M | 3% | Jun 2024 |
|
| Vanguard Group | 746k | $4.3M | 47% | Jun 2024 |
|
| Geode Capital Management | 302k | $2.1M | -2% | Sep 2024 |
|
| State Street Corporation | 179k | $1.0M | 34% | Jun 2024 |
|
| Charles Schwab Investment Management | 116k | $814k | -19% | Sep 2024 |
|
| DAFNA Capital Management | 112k | $787k | -7% | Sep 2024 |
|
| Northern Trust | 105k | $738k | -2% | Sep 2024 |
|
| Bridgeway Capital Management | 58k | $337k | 0% | Jun 2024 |
|
| Baker Bros. Advisors | 53k | $370k | 0% | Sep 2024 |
|
| Renaissance Technologies | 46k | $321k | -16% | Sep 2024 |
|
| Jpmorgan Chase & Co | 34k | $238k | 548% | Sep 2024 |
|
| Barclays | 33k | $233k | 51% | Sep 2024 |
|
| Dimensional Fund Advisors | 31k | $216k | 206% | Sep 2024 |
|
| Trexquant Investment | 30k | $213k | 100% | Sep 2024 |
|
| Bank of America Corporation | 30k | $210k | 9% | Sep 2024 |
|
| Bank of New York Mellon | 30k | $207k | -19% | Sep 2024 |
|
| Goldman Sachs Group | 24k | $141k | 100% | Jun 2024 |
|
| Exchange Traded Concepts | 20k | $142k | -53% | Sep 2024 |
|
| Rhumbline Advisers | 18k | $124k | 10% | Sep 2024 |
|
| Morgan Stanley | 17k | $100k | 0% | Jun 2024 |
|
| Squarepoint Ops | 17k | $100k | 100% | Jun 2024 |
|
| American Century Companies | 15k | $108k | 100% | Sep 2024 |
|
| Nuveen Asset Management | 12k | $69k | 0% | Jun 2024 |
|
| Citigroup | 11k | $79k | 121% | Sep 2024 |
|
| AAFCPAs Wealth Management | 11k | $75k | 0% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 6.5k | $45k | -1% | Sep 2024 |
|
| Wells Fargo & Company | 5.4k | $38k | 4% | Sep 2024 |
|
| Tower Research Capital | 3.8k | $22k | 363% | Jun 2024 |
|
| New York State Common Retirement Fund | 2.3k | $16k | 0% | Sep 2024 |
|
| Royal Bank of Canada | 1.3k | $11k | 14% | Sep 2024 |
|
| Russell Investments | 1.2k | $6.8k | 424% | Jun 2024 |
|
| California State Teachers Retirement System | 856.00 | $6.0k | 0% | Sep 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 800.00 | $5.6k | 0% | Sep 2024 |
|
| Summit Investment Advisors | 695.00 | $4.9k | 0% | Sep 2024 |
|
| Federation des caisses Desjardins du Quebec | 400.00 | $2.8k | 0% | Sep 2024 |
|
| Amalgamated Bank | 378.00 | $3.0k | 0% | Sep 2024 |
|
| Efficient Wealth Management | 88.00 | $0 | 0% | Sep 2024 |
|
| Capital Advisors | 48.00 | $0 | 0% | Sep 2024 |
|
| CWM | 46.00 | $0 | 100% | Sep 2024 |
|
| Sterling Capital Management | 37.00 | $259.000000 | 100% | Sep 2024 |
|
| Capital Performance Advisors | 32.00 | $224.000000 | 100% | Sep 2024 |
|
Who sold out of Acrivon Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Paradigm Biocapital Advisors | Jun 2024 | 660k | $3.8M |
| Jane Street | Jun 2024 | 31k | $178k |
| Occudo Quantitative Strategies | Jun 2024 | 13k | $73k |
| XTX Topco | Jun 2024 | 11k | $61k |
| Advisor Group Holdings | Mar 2024 | 5.1k | $36k |